A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA studyShun Lü, Weiguo Su, Zhendong Chen et al.|Lung Cancer|2020Cited by 21
Peritumoral lymphatic microvessel density is related to poor prognosis in lung adenocarcinoma: A retrospective study of 65 casesBicheng Zhang, Jianfei Gao, Sha Guan et al.|Experimental and Therapeutic Medicine|2012Cited by 11
Clinical study of comparing LP and TP regimens in the treatment of advanced non-small cell lung cancerJianfei Gao, Bicheng Zhang, Sha Guan et al.|The Chinese-German Journal of Clinical Oncology|2010Cited by 4